Dr. Richard Kube Discusses The Future Of Spine Biologics

Becker’s Spine Review is a publication for orthopedic and spine surgeons and surgery center administrators. Each week, Becker’s releases additions to their Ask Spine Surgeons series, and earlier this month, spine surgeons were asked to share where they think the future of spine biologics is headed. Check out Dr. Richard Kube’s response, below!   Question:… Continue Reading Dr. Richard Kube Discusses The Future Of Spine Biologics

Dr. Richard Kube: 12-month Results of Clinical Study on Sacroiliac Joint Fusion

Zyga Technology, Inc., a medical device company focused on the design, development and commercialization of minimally invasive devices to treat underserved conditions of the lumbar spine, today announced the publication of 12-month clinical and radiographic results in The Open Orthopaedics Journal. The study evaluated long-term fusion and pain reduction in patients receiving SImmetry® Sacroiliac Joint… Continue Reading Dr. Richard Kube: 12-month Results of Clinical Study on Sacroiliac Joint Fusion

Dr. Richard Kube — 15th Annual Spine, Orthopedics, and Pain Management ASC Conference

Addressing Key Business, Clinical and Legal Issues The 15th Annual Spine, Orthopedic and Pain Management-Driven ASC Conference + The Business of Spine: Improving Profits, Business and Legal Issues, provides the ideal opportunity to meet orthopedic, spine and pain management surgeons, administrators, and owners and operators of ambulatory surgery centers.

What Makes A Patient Eligible for Stem Cell Therapy?

Degenerative disc disease in your spine isn’t really a disease, but the term used to describe common age—or injury–related—changes to the discs in your spine. These include the loss of fluid/hydration in the discs, which can result in reduced flexibility, and tears or cracks in the outer layer of the disc that can cause it… Continue Reading What Makes A Patient Eligible for Stem Cell Therapy?